ISRCTN68689512已完成未知
Magnetic Sentinel Node and Occult Lesion Localisation: A feasibility study using magnetic nanoparticles for sentinel node biopsy and localisation of occult breast cancers
King's College London (UK)0 个研究点目标入组 50 人开始时间: 2013年9月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Patients with operable breast cancer visible on ultrasound and suitable for SLNB 2. Neoadjuvant chemotherapy sub-protocol:
- •Patients with breast cancer due to undergo neoadjuvant chemotherapy and post-chemotherapy SLNB
- •3. Target Gender: Female ; Lower Age Limit 18 years
排除标准
- •1. Intolerance / hypersensitivity to iron or dextran compounds or Sienna +
- •2. Patients who cannot / do not receive radioisotope for SLNB
- •3. Patients with an iron overload disease
- •4. Patients with pacemakers or other implantable devices in the chestwall
研究者
相似试验
已完成
2 期
MagSNOLL: Magnetic Sentinel Node and Occult Lesion Localisation: A feasibility study using magnetic nano particles for sentinel node biopsy and localization of occult breast cancers.NL-OMON44817niversiteit Twente60
尚未招募
不适用
MagSNOLL multicenter StudyPatients (male or female) with histologically proven non-palpable breast cancer visible on ultrasound and suitable for SLNBNL-OMON26455Guy's and St Thomas Hospitals, UK60
已完成
不适用
The MOLL trial - Magnetic lesion localisation for breast cancerSpecialty: Cancer, Primary sub-specialty: Breast CancerUKCRC code/ Disease: Cancer/ Malignant neoplasm of breastBreast CancerCancerISRCTN74635349Guy's and St Thomas' NHS Foundation Trust20
已完成
不适用
Magnetic tracer in the sentinel node procedure in breast cancer: the non-radioactive alternative for radio-isotopessentinel node procedure1000629110006295NL-OMON49099Zuyderland Medisch Centrum40
尚未招募
不适用
Magnetic marker localization for non-palpable breast cancerBreast CancerNL-OMON23325one10